Skip to main content
Premium Trial:

Request an Annual Quote

Two RNAi-Related Patent Applications Published by the US Patent Office: May 6, 2005


Title: Nucleic Acid Nematicides.

Number: 20050091713.

Filed: Dec. 29, 2004.

PCT Filed: Dec. 17, 2002.

Inventor: Howard Atkinson, University of Leeds.

"The invention is the identification of double-stranded RNA nematicides to nematode genes and a screening assay for the identification of agents, typically dsRNA's, with nematicidal activity," the patent application's abstract states.

Title: Methods of Inhibiting Inflammation.

Number: 20050090426.

Filed: March 24, 2004.

Inventor: Richard Blumberg, Harvard Medical School.

"The invention provides a method of inhibiting inflammation in a mammal, by administering to the mammal composition containing a compound which inhibits the expression or activity of a microsomal triglyceride transfer protein," the patent application's abstract states.

The application specifically claims the inhibition of inflammation by administering to an inflamed tissue an siRNA inhibiting microsomal triglyceride transfer protein.


The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.